4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-016800
Chief Executive Officer sold 79,712 shares at $5.95 ($474,239)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| De Backer Marianne Chief Executive Officer | 2025-04-03 | Sale 10b5-1 | −79,712 | $5.95 | $474,239 | 769,505 | D |
| Open-market sales · 79,712 sh · avg $5.95 · $474,239 | |||||||
Loading xslF345X05/wk-form4_1743798213.xml…